<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6275</number>
    <updateDate>2025-01-16T11:48:07Z</updateDate>
    <updateDateIncludingText>2025-01-16T11:48:07Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-11-07</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 184 (Tuesday, November 7, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. PEREZ:H.R. 6275.Congress has the power to enact this legislation pursuantto the following:Article 1 of the US ConstitutionThe single subject of this legislation is:health[Page H5545]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif17</systemCode>
            <name>Commerce, Manufacturing, and Trade Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2023-11-10T15:12:02Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-11-07T15:01:00Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-11-07T15:01:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2023-11-10</actionDate>
        <committees>
          <item>
            <systemCode>hsif17</systemCode>
            <name>Commerce, Manufacturing, and Trade Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Innovation, Data, and Commerce.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-11-07</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-11-07</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-11-07</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-11-07</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000600</bioguideId>
        <fullName>Rep. Perez, Marie Gluesenkamp [D-WA-3]</fullName>
        <firstName>Marie</firstName>
        <lastName>Perez</lastName>
        <party>D</party>
        <state>WA</state>
        <middleName>Gluesenkamp</middleName>
        <district>3</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C001117</bioguideId>
        <fullName>Rep. Casten, Sean [D-IL-6]</fullName>
        <firstName>Sean</firstName>
        <lastName>Casten</lastName>
        <party>D</party>
        <state>IL</state>
        <district>6</district>
        <sponsorshipDate>2023-11-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001078</bioguideId>
        <fullName>Rep. Connolly, Gerald E. [D-VA-11]</fullName>
        <firstName>Gerald</firstName>
        <lastName>Connolly</lastName>
        <party>D</party>
        <state>VA</state>
        <middleName>E.</middleName>
        <district>11</district>
        <sponsorshipDate>2023-11-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001223</bioguideId>
        <fullName>Rep. Magaziner, Seth [D-RI-2]</fullName>
        <firstName>Seth</firstName>
        <lastName>Magaziner</lastName>
        <party>D</party>
        <state>RI</state>
        <district>2</district>
        <sponsorshipDate>2024-07-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Competition and antitrust</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Consumer affairs</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Federal Trade Commission (FTC)</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Intellectual property</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Judicial review and appeals</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Licensing and registrations</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2024-05-09T17:57:59Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-11-22T02:45:39Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-11-07</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-01-24T21:24:48Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Protecting Consumer Access to Generic Drugs Act of &lt;/b&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. &lt;/p&gt; &lt;p&gt;Specifically, such an agreement shall, with some exceptions, be a violation of the bill if the filer of a subsequent application to market a drug or biological product receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the subsequent drug or biological product. (Typically, a subsequent application seeks to market a generic or biosimilar version of a patented drug or biological product.)&lt;/p&gt; &lt;p&gt;Penalties for violations of the bill include civil penalties and loss of the 180-day exclusivity period for a generic drug. The Federal Trade Commission (FTC) shall have exclusive authority to litigate to enforce the bill. &lt;/p&gt; &lt;p&gt;When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing or sale of a drug, the manufacturers shall certify that the material they have given the FTC concerning the agreement contains (1) the complete agreement; and (2) any agreements related to the main agreement, including descriptions of any oral agreements or representations.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Protecting Consumer Access to Generic Drugs Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Protecting Consumer Access to Generic Drugs Act of 2023</title>
        <updateDate>2024-07-23T08:05:34Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Protecting Consumer Access to Generic Drugs Act of 2023</title>
        <updateDate>2024-05-24T13:35:28Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.</title>
        <updateDate>2024-03-18T21:47:04Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-11-07T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr6275ih/xml/BILLS-118hr6275ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-11-10</actionDate>
      <text>Referred to the Subcommittee on Innovation, Data, and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
